Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic

Prostate

Volumn 76, Issue 1, 2016, Pages 68-79

  Samsonov, Roman ^a,b   Shtam, Tatiana ^c   Burdakov, Vladimir ^c   Glotov, Andrey ^d   Tsyrlina, Evgenia ^a   Berstein, Lev ^a   Nosov, Alexander ^a   Evtushenko, Vladimir ^b   Filatov, Michael ^c   Malek, Anastasia ^a,c,e  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b Russian Center for Research in Radiological and Surgical Technologies   (Russian Federation)

^c PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

^d ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^e BAR ILAN UNIVERSITY   (Israel)

Author keywords

diagnostic; exosomes; lectin; miRNA; prostate cancer

Indexed keywords

CONCANAVALIN A; LECTIN; MICRORNA; PHYTOHEMAGGLUTININ; BIOLOGICAL MARKER;

ADULT; AGED; AGGLUTINATION TEST; ARTICLE; ATOMIC FORCE MICROSCOPY; AUTOMATION; CANCER CELL LINE; CANCER DIAGNOSIS; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROPHORESIS; EXOSOME; HUMAN; HUMAN CELL; MALE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; URINALYSIS; CANCER GRADING; CANCER STAGING; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; REPRODUCIBILITY; TUMOR CELL CULTURE; URINE;

ADULT; AGED; AGGLUTINATION TESTS; BIOMARKERS; EXOSOMES; HUMANS; LECTINS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TUMOR CELLS, CULTURED;

EID: 84955181667     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23101     Document Type: Article

References (50)

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E,. Cancer treatment and survivorship statistics CA Cancer J Clin 2012; 62 (4): 220-241.
2. Pisitkun T, Shen RF, Knepper MA,. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101 (36): 13368-13373.
3. Vlassov AV, Magdaleno S, Setterquist R, Conrad R,. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012; 1820 (7): 940-948.
4. Ranghino A, Dimuccio V, Papadimitriou E, Bussolati B,. Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration. Clin Kidney J 2015; 8 (1): 23-30.
5. Gamez-Valero A, Lozano-Ramos SI, Bancu I, Lauzurica-Valdemoros R, Borras FE,. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol 2015; 6: 6.
6. Corbetta S, Raimondo F, Tedeschi S, Syren ML, Rebora P, Savoia A, Baldi L, Bettinelli A, Pitto M,. Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes. Nephrol Dial Transplant 2015; 30 (4): 621-630.
7. Properzi F, Logozzi M, Fais S,. Exosomes: the future of biomarkers in medicine. Biomark Med 2013; 7 (5): 769-778.
8. Drake RR, Kislinger T,. The proteomics of prostate cancer exosomes. Expert Rev Proteomics 2014; 11 (2): 167-177.
9. Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pasa-Tolic L, Jenster G,. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS ONE 2013; 8 (12): e.2589.
10. Hessvik NP, Sandvig K, Llorente A,. Exosomal miRNAs as biomarkers for prostate cancer. Front Genet 2013; 4: 36.
11. Zeringer E, Barta T, Li M, Vlassov AV,. Strategies for isolation of exosomes. Cold Spring Harb Protoc 2015; 2015 (4):pdb top074476.
12. Thery C, Amigorena S, Raposo G, Clayton A,. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3:Unit 3 2006; 22.
13. Cheruvanky A, Zhou H, Pisitkun T, Kopp JB, Knepper MA, Yuen PS, Star RA,. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol 2007; 292 (5): F1657-F1661.
14. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK,. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010; 4 (3): 214-222.
15. Jeppesen DK, Hvam ML, Primdahl-Bengtson B, Boysen AT, Whitehead B, Dyrskjot L, Orntoft TF, Howard KA, Ostenfeld MS,. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J Extracell Vesicles 2014; 3: 25011.
16. Tauro BJ, Greening DW, Mathias RA, Mathivanan S, Ji H, Simpson RJ,. Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 2013; 12 (3): 587-598.
17. Vyas N, Walvekar A, Tate D, Lakshmanan V, Bansal D, Lo Cicero A, Raposo G, Palakodeti D, Dhawan J,. Vertebrate Hedgehog is secreted on two types of extracellular vesicles with different signaling properties. Scientific reports 2014; 4: 7357.
18. Sharon N,. Lectins: past, present and future. Biochem Soc Trans 2008; 36 (Pt 6): 1457-1460.
19. Marleau AM, Chen CS, Joyce JA, Tullis RH,. Exosome removal as a therapeutic adjuvant in cancer. J Transl Med 2012; 10: 134.
20. Escrevente C, Grammel N, Kandzia S, Zeiser J, Tranfield EM, Conradt HS, Costa J,. Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells. PLoS ONE 2013; 8 (10): e78631.
21. Escrevente C, Keller S, Altevogt P, Costa J,. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 2011; 11: 108.
22. Gerlach JQ, Kruger A, Gallogly S, Hanley SA, Hogan MC, Ward CJ, Joshi L, Griffin MD,. Surface glycosylation profiles of urine extracellular vesicles. PloS ONE 2013; 8 (9): e74801.
23. Echevarria J, Royo F, Pazos R, Salazar L, Falcon-Perez JM, Reichardt NC,. Microarray-based identification of lectins for the purification of human urinary extracellular vesicles directly from urine samples. Chembiochem 2014; 15 (11): 1621-1626.
24. Kosanovic M, Jankovic M,. Isolation of urinary extracellular vesicles from Tamm- Horsfall protein-depleted urine and their application in the development of a lectin-exosome-binding assay. Biotechniques 2014; 57 (3): 143-149.
25. Korzeniewski N, Tosev G, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S,. Identification of cell-free microRNAs in the urine of patients with prostate cancer. Urol Oncol 2015; 33 (1):16 e17-22.
26. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M,. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108 (12): 5003-5008.
27. Turchinovich A, Weiz L, Langheinz A, Burwinkel B,. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39 (16): 7223-7233.
28. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT,. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13 (4): 423-433.
29. Simpson RJ, Jensen SS, Lim JW,. Proteomic profiling of exosomes: current perspectives. Proteomics 2008; 8 (19): 4083-4099.
30. Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV, Filatov MV,. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal 2013; 11: 88.
31. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, Kuslich C, Visakorpi T, Hamdy FC,. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012; 106 (4): 768-774.
32. Hessvik NP, Phuyal S, Brech A, Sandvig K, Llorente A,. Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim Biophys Acta 2012; 1819 (11-12): 1154-1163.
33. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM,. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99 (24): 15524-15529.
34. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL,. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141 (5): 672-675.
35. Di Leva G, Croce CM,. MiRNA profiling of cancer. Curr Opin Genet Dev 2013; 23 (1): 3-11.
36. Allegra A, Alonci A, Campo S, Penna G, Petrungaro A, Gerace D, Musolino C,. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 2012; 41 (6): 1897-1912.
37. Rana S, Malinowska K, Zoller M,. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013; 15 (3): 281-295.
38. Jackson BL, Grabowska A, Ratan HL,. MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers. BMC cancer 2014; 14: 930.
39. Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA,. The fusion of two worlds: non-coding RNAs and extracellular vesicles-diagnostic and therapeutic implications (Review). Int J Oncol 2015; 46 (1): 17-27.
40. Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, Cheng HH, Arroyo JD, Meredith EK, Gallichotte EN, Pogosova-Agadjanyan EL, Morrissey C, Stirewalt DL, Hladik F, Yu EY, Higano CS, Tewari M,. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 2014; 111 (41): 14888-14893.
41. Arndt NX, Tiralongo J, Madge PD, von Itzstein M, Day CJ,. Differential carbohydrate binding and cell surface glycosylation of human cancer cell lines. J Cell Biochem 2011; 112 (9): 2230-2240.
42. Yaman Agaoglu, Dizdar M, Darendeliler Y, Holdenrieder E, Dalay S, Gezer N,. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol 2011; 32 (3): 583-588.
43. Zhang HL, Yang LF, Zhu Y, Yao XD, Zhang SL, Dai B, Zhu YP, Shen YJ, Shi GH, Ye DW,. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. The Prostate 2011; 71 (3): 326-331.
44. Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM,. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. The Prostate 2012; 72 (13): 1469-1477.
45. Gonzales JC, Fink LM, Goodman OB Jr., Symanowski JT, Vogelzang NJ, Ward DC,. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer. Clin Genitourin Cancer 2011; 9 (1): 39-45.
46. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M,. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105 (30): 10513-10518.
47. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T, Beissbarth T, Kuner R, Sultmann H,. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 2011; 128 (3): 608-616.
48. Selth LA, Townley S, Gillis JL, Ochnik AM, Murti K, Macfarlane RJ, Chi KN, Marshall VR, Tilley WD, Butler LM,. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer 2012; 131 (3): 652-661.
49. Larne O, Martens-Uzunova E, Hagman Z,. Edsjo A, Lippolis G, den Berg MS, Bjartell A, Jenster G, Ceder Y. miQ-a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer 2013; 132 (12): 2867-2875.
50. Lazaro-Ibanez E, Sanz-Garcia A, Visakorpi T, Escobedo-Lucea C, Siljander P, Ayuso-Sacido A, Y,. Liperttula M. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes. The Prostate 2014; 74 (14): 1379-1390.